https://pharmadog.xyz/news/618351 pharmadog en 2026-10-31T11:00:00.000Z Midterm election outcomes could reshape U.S. health policy, experts say https://pharmadog.xyz/news/618307 pharmadog en 2026-10-31T10:00:28.000Z Halloween edition of Endpoints Weekly teases Anthropic biotech acquisition and Jake Van Naarden’s deal strategy https://pharmadog.xyz/news/615714 pharmadog en 2026-10-30T20:32:08.000Z FDA grants accelerated approval to first plasmid DNA immunotherapy for adult recurrent respiratory papillomatosis https://pharmadog.xyz/news/614871 pharmadog en 2026-10-30T16:16:51.000Z Sanofi plans to pursue higher European drug prices rather than delay product launches under Trump policy https://pharmadog.xyz/news/615082 pharmadog en 2026-10-30T16:16:00.000Z Vitality Works recalls 365 Whole Foods Ashwagandha capsules over possible Salmonella contamination https://pharmadog.xyz/news/614935 pharmadog en 2026-10-30T16:00:00.000Z Moderna and Merck’s individualized cancer vaccine shows promising melanoma results but shares tumble after ESMO presentation https://pharmadog.xyz/news/614703 pharmadog en 2026-10-30T15:47:13.000Z Gilead places CAR-T program on partial hold after ICANS cases; Agios delays PDUFA submission https://pharmadog.xyz/news/614728 pharmadog en 2026-10-30T15:42:22.000Z AbbVie beats Q3 expectations, lifts full-year EPS outlook as immunology and neuroscience drive growth https://pharmadog.xyz/news/614704 pharmadog en 2026-10-30T15:36:16.000Z AstraZeneca hints restructuring may trim R&D budget and move trials to emerging markets https://pharmadog.xyz/news/134233 pharmadog en 2026-10-30T15:30:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/614729 pharmadog en 2026-10-30T15:23:41.000Z AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expected https://pharmadog.xyz/news/614730 pharmadog en 2026-10-30T15:07:04.000Z Regeneron posts $5.1 billion Q3 revenue, beating forecasts and highlighting strong sales of Dupixent, Eylea HD and Libtayo